Rapid genetic analysis of oculocutaneous albinism (OCA1) using denaturing high performance liquid chromatography (DHPLC) system

Prenatal Diagnosis

Volumn 26, Issue 5, 2006, Pages 466-470

  Lin, Shin Yu ^a   Chien, Shu Chin ^a   Su, Yi Ning ^a   Lee, Chien Nan ^a   Chen, Chih Ping ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

DHPLC; OCA; Prenatal genetic diagnosis

Indexed keywords

ADULT; ALBINISM, OCULOCUTANEOUS; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC SCREENING; HUMANS; MALE; MONOPHENOL MONOOXYGENASE; NUCLEIC ACID DENATURATION; PEDIGREE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 33646771360     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1439     Document Type: Article

References (19)

1. Akeo K, Shirai S, Okisaka S, et al. 1996. Histology of fetal eyes with oculocutaneous albinism. Arch Ophthalmol 114(5): 613-616.
2. Baxter LL, Pavan WJ. 2002. The oculocutaneous albinism type IV gene MATP is a new marker of pigment cell precursors during mouse embryonic development. Mech Dev 116(1-2): 209-212.
3. Boissy RE, Richmond B, Huizing M, et al. 2005. Melanocyte-specific proteins are aberrantly trafficked in rnelanocytes of Hermansky-Pudlak syndrome-type 3. Am J Pathol 166(1): 231-240.
4. Chien SC, Lee CN, Hung CC, Tsao PN, Su YN, Hsieh FJ. 2003. Rapid prenatal diagnosis of X-linked chronic granulomatous disease using a denaturing high-performance liquid chromatography (DHPLC) system. Prenat Diagn 23(13): 1092-1096.
5. Eady RA, Gunner DB, Garner A, Rodeck CH. 1983. Prenatal diagnosis of oculocutaneous albinism by electron microscopy of fetal skin. J Invest Dermatol 80(3): 210-212.
6. Hsieh YY, Wu JY, Chang CC, et al. 2001. Prenatal diagnosis of oculocutaneous albinism two mutations located at the same allele. Prenat Diagn 21(3): 200-201.
7. Hung CC, Su YN, Lin CY, et al. 2005. Denaturing HPLC Coupled with multiplex PCR for Rapid Detection of Large Deletions in Duchenne Muscular Dystrophy Carriers. Clin Chem. 51: 1252-1256.
8. Kato A, Fukai K, Oiso N, et al. 2003. A novel P gene missense mutation in a Japanese patient with oculocutaneous albinism type II (OCA2). J Dermatol Sci 31(3): 189-192.
9. Kikuchi A, Shimizu H, Nishikawa T. 1995. Epidermal melanocytes in normal and tyrosinase-negative oculocutaneous albinism fetuses. Arch Dermatol Res 287(6): 529-533.
10. Levy ML, Magee W. 1994. Postnatal testing for unusual genodermatoses. Dermatol Clin 12(1): 93-97.
11. Getting WS. 2000. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation. Pigment Cell Res 13(5): 320-325.
12. Getting WS, Fryer JP, Shriram S, King RA. 2003. Oculocutaneous albinism type 1: the last 100 years. Pigment Cell Res 16(3): 307-311.
13. Getting WS, Garrett SS, Brott M, King RA. 2005. P gene mutations associated with oculocutaneous albinism type II (OCA2). Hum Mutat 25(3): 323-323.
14. Okulicz JF, Shah RS, Schwartz RA, Janniger CK. 2003. Oculocutaneous albinism. J Eur Acad Dermatol Venereol 17(3): 251-256.
15. Rosenmann E, Rosenmann A, Ne'eman Z, Lewin A, Bejarano-Achache I, Blumenfeld A. 1999. Prenatal diagnosis of oculocutaneous albinism type I: review and personal experience. Pediatr Dev Pathol 2(5): 404-414.
16. Shimizu H. Ishiko A, Kikuchi A, Akiyama M, Suzumori K, Nishikawa T. 1994. Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism by an electron microscopic dopa reaction test of fetal skin. Prenat Diagn 14(6): 442-450.
17. Spritz RA. 1994. Molecular genetics of oculocutaneous albinism. Hum Mol Genet 3 Spec No: 1469-1475.
18. Su YN, Lee CN, Hung CC, et al. 2003. Rapid detection of beta-globin gene (HBB) mutations coupling heteroduplex and primer-extension analysis by DHPLC. Hum Mutat 22(4): 326-336.
19. Suzuki T, Inagaki K, Fukai K, Obana A, Lee ST, Tomita Y. 2005. A Korean case of oculocutaneous albinism type IV caused by a D157N mutation in the MATP gene. Br J Dermatol 152(1): 174-175.